Atapour Abdolamir, Eshaghian Atefeh, Taheri Diana, Dolatkhah Shahaboddin
Department of Nephrology, Isfahan Kidney Diseases Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Saudi J Kidney Dis Transpl. 2015 Sep;26(5):962-5. doi: 10.4103/1319-2442.164578.
There is an increasing need for renal replacement therapy due to the growing number of cases with chronic kidney disease leading to end-stage renal disease. Two modalities of dialysis available are hemodialysis (HD) and peritoneal dialysis (PD). In this study, we aimed to compare the financial aspects of HD with PD. A total of 53 patients on HD and 43 patients on PD were included in the study and were assessed for several financial aspects of dialysis. The data collected were analyzed using SPSS-18. A statistically significant difference was noted between the HD and PD groups in the need for diagnostic tests, drugs, hospitalization, etc, with PD being less expensive. We strongly suggest physicians in our area to use PD on a larger number of patients for better financial outcome.
由于慢性肾脏病导致终末期肾病的病例数量不断增加，对肾脏替代治疗的需求也日益增长。现有的两种透析方式是血液透析（HD）和腹膜透析（PD）。在本研究中，我们旨在比较血液透析和腹膜透析的财务状况。共有53例接受血液透析的患者和43例接受腹膜透析的患者纳入本研究，并对透析的几个财务方面进行了评估。使用SPSS-18对收集的数据进行分析。血液透析组和腹膜透析组在诊断检查、药物、住院等方面的需求存在统计学上的显著差异，腹膜透析成本更低。我们强烈建议我们地区的医生对更多患者使用腹膜透析，以获得更好的财务结果。
